RxDoctor Payments Data

Brittany Nguyen

Women's Health · Birmingham, ALNPI 1932608809

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 25.9% of the total. Reporting peaked in 2022 at $801 and has fallen 50.2% since, to $399 in 2025.

$2,797in general payments, 2019–2025

Across 162 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$723
  • AbbVie$298
  • Millicent US Inc$271
  • Mayne Pharma Commercial LLC$234
  • Scynexis, Inc.$221
  • Pfizer$177
  • plus $873 from 13 others

What the payments were for

  • Food & beverage$2,797100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,797 in reported general payments places this provider in the 85th percentile of 107 women's health providers in Alabama.

See all women's health providers in Alabama

Medicare billing

Part B allowed, 2024
$2,337
Medicare patients
19
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProgesteroneProgesterone, Micronized24$1,625
Spironolactone15$258

Paid to pharmacies, not to this prescriber.

Other women's health in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →